Skip to main content
Published locations for Benralizumab proves noninferior to mepolizumab for rare vasculitis, EGPA
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Benralizumab proves noninferior to mepolizumab for rare vasculitis, EGPA
User login
Username
Password
Reset your password
/content/benralizumab-proves-noninferior-mepolizumab-rare-vasculitis-egpa
/rheumatologynews/article/266648/lupus-connective-tissue-diseases/benralizumab-proves-noninferior
/rheumatology/article/266648/lupus-connective-tissue-diseases/benralizumab-proves-noninferior